Collected Analabs at RM 1.62

I collected another 10,000 Analabs shares at RM 1.62 ...
Wish me LUCK !

Analabs ~ 03 Nov 09 : buy back 66,000 at RM 1.148

*
Notice of Shares Buy Back - Immediate Announcement
Date of Buy Back : 03/11/2009
Description of Shares Purchased : Ordinary shares of RM1.00 each
*
No. of Shares Purchased : 66,000 shares
Minimum Price Paid For Each Share Purchased : RM 1.140
Maximum Price Paid For Each Share Purchased : RM 1.150
Total Consideration Paid : RM 75,800.00
*
No. of Shares Purchased Retained in Treasury : 66,000 shares
No. of Shares Which Are Proposed To Be Cancelled : 0 shares
Cumulative Net Outstanding Treasury Shares As At To-Date : 750,000 shares
Adjusted Issued Capital After Cancellation : 0
*
Date Lodged With Registrar of Company :
Lodged By :
Remarks: N/A
Submitted By:
CHEW MEI LING
03/11/2009 05:26 PM
*

Analabs ~ 04 Nov 09 : Value Chart

04 Nov 2009
*

Analabs

*

price 1.14

EPS 0.16

EPS 12 mo 0.18

ncal 09 nov 0.89

ncal 10 nov 1.07

eps value 10 nov 1.32

fair value 10 nov 1.40

upside 22%

*

My call to myself : to add more at RM 1.10

*

Analabs (RM 1.09) ~ 10 Q1 report

Review of the Performance

For the quarter under review, the Group recorded a revenue of RM10.27 million, 26% below the revenue of the corresponding quarter of the preceding year as there was no contribution from the aquaculture operating unit which was undergoing upgrading and maintenance of its site during the current quarter. The other operating units have also registered a decline in revenue due to the weak prevailing operating environment.

As there was no revenue from the aquaculture operating unit, the Group’s profit before tax was lower by 25% when compared to the corresponding quarter of the preceding year. The corresponding reduction in the cost of procuring recycled products and the cost savings measures undertaken by the Group was effective in enabling certain operating units to register a higher profit despite lower turnover.


Prospects

On the backdrop of improving general economic climate, the Group’s prospects for the current financial year 2010 is expected to be satisfactory.

**********************************************************************************

The details of investments in quoted securities as at the end of the current financial quarter are set out below :-

Total investments at cost RM 17,036 m
Total investments at carrying value RM 15,836 m
Total investments at market value RM 15,516 m

.

Analabs ~ Messrs Howarth replacing KPMG as Auditors

Notice by way of an Addendum to the Notice of 11th AGM dated 10 September 2009

THAT Messrs Horwath be and is hereby appointed Auditors of the Company
in place of the retiring Auditors, Messrs KPMG
to hold office until the conclusion of the next Annual General Meeting of the Company
AND THAT authority be and is hereby given for the Directors to determine their remuneration.

Company Secretaries
10 Sep 2009

Proposed Acquisition of COVERIGHT is deemed completed

PROPOSED ACQUISITION

ANALABS RESOURCES BERHAD ("ANALABS" OR THE "COMPANY")
- PROPOSED ACQUISITION OF 100% EQUITY INTEREST IN COVERIGHT SURFACES MALAYSIA SDN BHD
FOR A CASH CONSIDERATION OF RM40.0 MILLION ("PROPOSED ACQUISITION")

We refer to the announcement dated 22 July 2009 wherein Analabs had on even date entered into a conditional share purchase agreement ("SPA") with Surfaces Holding B.V. (the "Vendor") for the acquisition of 100% equity interest in Coveright Surfaces Malaysia Sdn Bhd from the Vendor for a cash consideration of RM40.0 million.

On behalf of Analabs, OSK Investment Bank Berhad wishes to announce that the SPA has become unconditional.
Accordingly, the Proposed Acquisition is deemed to be completed.

This announcement is dated 7 September 2009.
*

Zhulian & Analabs

Let's compare for fun ...

Zhulian
Cash after Total Liabilities RM 0.13
Current asset include liquid security at market value after Total Liabilities RM 0.43
Current Share price RM 1.16

Analabs
Cash after Total Liabilities RM 0.26
Current asset include liquid security at market value after Total Liabilites RM 0.89
Current Share price RM 0.86

By Balance sheet comparison, it is obvious Analabs is more actractive than Zhulian.

How about earning. This is a little more tricky.
Analabs projected EPS will be at 18 sen per share.
Therefore it will be trading at PE of 4.8

For Zhulian to trade at PE 4.8 , its earning should be at 24 sen per share.
And even if Zhulian able to earn 24 sen per share, its balance sheet is still far less value compare to Analabs.

So, for Zhulian to be at par with Analabs value, either Zhulian must be able to earn more than 24 sen per share or Zhulian should trade at LOWER SHARE PRICE.

Analabs ~ EPS

Analabs ~ current trading at 78.5 sen , PE 4.48 ~ appears very attractive to me.